Search Login Register

Dihematoporphyrin Ether (Porfimer Sodium) Summary

Description: The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.

Also Known As: Porfimer Sodium; Photofrin; Dihematoporphyrin Ester; Photofrin II; Ether, Dihematoporphyrin Show All >>

Networked: 631 relevant articles (48 outcomes, 87 trials/studies) for this Drug

Key Diseases for which Dihematoporphyrin Ether is Relevant

  1. Neoplasms (Cancer) : 23 outcomes 31 studies in 293 results
  2. Squamous Cell Carcinoma (Epidermoid Carcinoma) : 7 outcomes 8 studies in 38 results
  3. Carcinoma (Carcinomatosis) : 4 outcomes 9 studies in 61 results
  4. Lung Neoplasms (Lung Cancer) : 4 outcomes 4 studies in 20 results
  5. Glioma (Gliomas) : 2 outcomes 5 studies in 21 results
Show All >>

Drugs Related to Dihematoporphyrin Ether

  1. 1-phenyl-3,3-dimethyltriazene (PDT)
  2. Dihematoporphyrin Ether (Porfimer Sodium)
  3. Photosensitizing Agents (Photosensitizers)
  4. Hematoporphyrin Derivative
  5. temoporfin
  6. Talaporfin (talaporfin sodium)
  7. Porphyrins
  8. Micelles
  9. LDL-Receptor Related Protein 1 (LDL-Receptor Related Protein)
  10. Poloxamer (Poloxamer 407)
Show All >>

Therapies Related to Dihematoporphyrin Ether

  1. Photochemotherapy (Photodynamic Therapy)
  2. Lasers (Laser)
  3. Drug Therapy (Chemotherapy)
  4. Dye Lasers
  5. Heterologous Transplantation (Xenotransplantation)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.